Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

A drug, proven to improve walking in people with MS, has been approved and given standard marketing authorisation by the European Commission (EC). 

Fampyra (prolonged release fampridine...

In a phase III trial, 2,199 relapsing remitting multiple sclerosis (RRMS) patients were randomised to receive one of two doses of laquinimod or a placebo. 

Last year drug makers stopped...

Scientists have discovered an experimental treatment that targets activated immune cells, killing them off and stopping autoimmune damage. 

In a study, researchers at Cincinnati Children’s...

Researchers from the University of British Columbia conducted a study to identify potential adverse events related to beta-interferon treatment for relapsing remitting multiple sclerosis (RRMS...

Ian Duncan, a professor of veterinary medicine at the University of Wisconsin-Madison, has pinpointed the cause of a serious neurological disease, very similar to multiple sclerosis (MS), in a...

According to research, exposure to the Epstein-Barr virus and herpes simplex virus type 1 (HSV-1) during childhood, in addition to a vitamin D deficiency, could increase the risk of developing...

Researchers from Queen Mary University of London have sampled spinal cords of thirteen people with multiple sclerosis (MS) and five healthy controls, and found that the spinal cord cross sectional...

Using technology designed by Case Western Reserve University and the Advanced Platform Technology and Functional Electrical Stimulation Centres at the Louis Stokes Cleveland Veterans Affairs...

Positive findings from a preliminary study involving the Epstein-Barr virus has highlighted a new possible approach for treating multiple sclerosis (MS).

Researchers believe the Epstein-...

Hundreds of British patients with secondary progressive multiple sclerosis (SPMS) are set to take part in a trial where they will be given simvastatin, a cheap anti-cholesterol drug that could...

Pages

Live Chat Software by Click4Assistance UK